Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer

References

• Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33:315–318.
   PubMed Web of Science ®Google Scholar
• Mariotto AB, Enewold L, Zhao J, et al. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Prev Biomarkers. 2020;29:1304–1312.
   PubMed Web of Science ®Google Scholar
• Greenfield S, Blanco DM, Elashoff RM, et al. Patterns of care related to age of breast cancer patients. Jama. 1987;257:2766–2770.
   PubMed Web of Science ®Google Scholar
• Waks AG, Winer EP. Breast cancer treatment: a review. Jama. 2019;321:288–300.
   PubMed Web of Science ®Google Scholar
• Haussmann J, Corradini S, Nestle-Kraemling C, et al. Recent advances in radiotherapy of breast cancer. Radiat Oncol. 2020;15:1–10.
   Web of Science ®Google Scholar
• Group EBCTC. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378:1707–1716.
   PubMed Web of Science ®Google Scholar
• Plichta JK, and Hughes KS. Omitting radiation in older breast cancer patients. Am J Hematol/Oncol. 2016;12:12-5.
   Google Scholar
• Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–2387.
   PubMed Web of Science ®Google Scholar
• Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351:963–970.
   PubMed Web of Science ®Google Scholar
• Tinterri C, Gatzemeier W, Zanini V, et al. Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast. 2009;18:373–377.
   PubMed Web of Science ®Google Scholar
• Corradini S, Niyazi M, Niemoeller OM, et al. Adjuvant radiotherapy after breast conserving surgery–a comparative effectiveness research study. Radiother Oncol. 2015;114:28–34.
   PubMed Web of Science ®Google Scholar
• Smith BD, Gross CP, Smith GL, et al. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98:681–690.
   PubMedGoogle Scholar
• Korah M, Sener S, Tripathy D. Implications of omitting radiation after breast conserving surgery in elderly women with low-risk invasive breast cancer. Int J Radiat Oncol Biol Phys. 2012;84:S34.
   Web of Science ®Google Scholar
• Cohen R, Li L, Citron W, et al. Improved survival with adjuvant radiation in elderly women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;84:S33–S34.
   Web of Science ®Google Scholar
• Joseph K, Zebak S, Alba V, et al. Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: results from a population-based study. Radiother Oncol. 2021;154:93–100.
   PubMed Web of Science ®Google Scholar
• Sen S, Wang S-Y, and Soulos PR, et al. Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer. JNCI. 2014 Mar;106(3):dju008. doi:https://doi.org/10.1093/jnci/dju008. Epub 2014 Mar 5.
   Google Scholar
• Boero IJ, Paravati AJ, Triplett DP, et al. The impact of radiotherapy costs on clinical outcomes in breast cancer. Radiother Oncol. 2015;117:393–399.
   PubMed Web of Science ®Google Scholar
• Punglia RS, Saito AM, Neville BA, et al. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. Bmj. 2010;340:c845–c845.
   PubMedGoogle Scholar
• Stokes ME, Thompson D, Montoya EL, et al. Ten‐year survival and cost following breast cancer recurrence: estimates from SEER‐medicare data. Value Health. 2008;11:213–220.
   PubMed Web of Science ®Google Scholar
• Medicare C, Services M. ASP drug pricing files. Center Medicare Medicaid Services. 2018.
   Google Scholar
• Centers for Medicare and Medicaid Services. Physician fee schedule search. https://www.cms.gov/apps/physician-fee-schedule/search/search-results.aspx?Y=1&T=0&HT=1&CT=0&H1=80053&H2=85025&M=5. Updated 2015. Accessed September/22, 2015.
   Google Scholar
• Ali AA, Tawk R, Xiao H, et al. Comparative effectiveness of radiotherapy for early‐stage hormone receptor‐positive breast cancer in elderly women using real‐world data. Cancer Med. 2019;8:117–127.
   PubMed Web of Science ®Google Scholar
• Selim AJ, Rogers W, Qian SX, et al. A preference-based measure of health: the VR-6D derived from the veterans RAND 12-item health survey. Qual Life Res. 2011;20:1337–1347.
   PubMed Web of Science ®Google Scholar
• Ali AA, Xiao H, Tawk R, et al. Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy. Curr Med Res Opin. 2017;33:391–400.
   PubMed Web of Science ®Google Scholar
• Li J, Vachani A, Epstein A, et al. A doubly robust approach for cost–effectiveness estimation from observational data. Stat Methods Med Res. 2018;27:3126–3138.
   PubMed Web of Science ®Google Scholar
• Sekhon JS. The Neyman-Rubin model of causal inference and estimation via matching methods. The Oxford handbook of political methodology. 2008;2:1–32.
   Google Scholar
• Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Cmaj. 1992;146:473.
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371:796–797.
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Weinstein MC, Mittleman MA, et al. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Mak. 2002;22:417–430.
   PubMed Web of Science ®Google Scholar
• Lee CP, Chertow GM, Zenios SA. An empiric estimate of the value of life: updating the renal dialysis cost‐effectiveness standard. Value Health. 2009;12:80–87.
   PubMed Web of Science ®Google Scholar
• Deshmukh AA, Shirvani SM, Lal L, et al. Cost-effectiveness analysis comparing conventional, hypofractionated, and intraoperative radiotherapy for early-stage breast cancer. JNCI. 2017;109:djx068.
   Google Scholar